Human DRAK2 protein

SKU: orb753676

Description

Recombinant human DRAK2 protein

Research Area

Apoptotic, Cancer, Epigenetics, Neuroscience, Signaling Pathways

Images & Validation

• Tested Applications: ELISA, WB
• Application Notes:
  Centrifuge the vial at 10,000 rpm for 1 minute, reconstitute at 200 μg/ml in sterile distilled water by gentle pipetting 2-3 times, don’t vortex

Key Properties

• Source: E.Coli
• Reactivity: Human
• Tag: N-terminal His Tag or N-terminal His-IF2DI Tag, determined during production process
• Expression Region: 1-372
• MW: 40.8 kDa
• Purity: Greater than 95% as determined by SDS-PAGE

Storage & Handling

• Storage: -20°C for 12 months as lyophilized;2-8°C for 1 month under sterile conditions after reconstitution
• Buffer/Preservatives: Lyophilized from a 0.2 μm filtered solution in 10 mM Hepes, 500 mM NaCl with 5% trehalose, pH 7.4
• Expiration Date: 6 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

DAP kinase related apoptosis inducing protein, DAP kinase related apoptosis inducing protein kinase 2, DAP kinase-related apoptosis-inducing protein kinase 2, Death associated protein kinase related 2, DRAK 2, DRAK2, Serine/threonine kinase 17b, Serine/threonine kinase 17b apoptosis inducing, Serine/threonine protein kinase 17B, Serine/threonine-protein kinase 17B, ST17B_HUMAN, STK 17B, Stk17b

Quick Database Links

UniProt

O94768